Hydrophilic Interaction Liquid Chromatography-Electrospray Ionization Mass Spectrometry for Therapeutic Drug Monitoring of Metformin and Rosuvastatin in Human Plasma

Autor: George Migias, Ariadni Vonaparti, Giorgos Machairas, Irene Panderi, Dimitra Gennimata, Vasiliki Brakoulia, Constantinos Pistos, Nikolaos Antonopoulos
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Electrospray
Spectrometry
Mass
Electrospray Ionization

Electrospray ionization
therapeutic drug monitoring
Pharmaceutical Science
Mass spectrometry
030226 pharmacology & pharmacy
01 natural sciences
Article
Analytical Chemistry
lcsh:QD241-441
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
lcsh:Organic chemistry
Liquid chromatography–mass spectrometry
Drug Discovery
Ammonium formate
Protein precipitation
Humans
Sample preparation
Physical and Theoretical Chemistry
Rosuvastatin Calcium
HILIC
Chromatography
Hydrophilic interaction chromatography
010401 analytical chemistry
Organic Chemistry
nutritional and metabolic diseases
3. Good health
0104 chemical sciences
LC-MS
chemistry
Chemistry (miscellaneous)
Molecular Medicine
metformin
rosuvastatin
Chromatography
Liquid
Zdroj: Molecules
Volume 23
Issue 7
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 23, Iss 7, p 1548 (2018)
ISSN: 1420-3049
DOI: 10.3390/molecules23071548
Popis: In this work a hydrophilic interaction liquid chromatography/positive ion electrospray mass spectrometric assay (HILIC/ESI-MS) has been developed and fully validated for the quantitation of metformin and rosuvastatin in human plasma. Sample preparation involved the use of 100 &mu
L of human plasma, following protein precipitation and filtration. Metformin, rosuvastatin and 4-[2-(propylamino) ethyl] indoline 2 one hydrochloride (internal standard) were separated by using an X-Bridge-HILIC BEH analytical column (150.0 ×
2.1 mm i.d., particle size 3.5 &mu
m) with isocratic elution. A mobile phase consisting of 12% (v/v) 15 mM ammonium formate water solution in acetonitrile was used for the separation and pumped at a flow rate of 0.25 mL min&minus
1. The linear range of the assay was 100 to 5000 ng mL&minus
1 and 2 to 100 ng mL&minus
1 for metformin and rosuvastatin, respectively. The current HILIC-ESI/MS method allows for the accurate and precise quantitation of metformin and rosuvastatin in human plasma with a simple sample preparation and a short a chromatographic run time (less than 15 min). Plasma samples from eight patients were further analysed proving the capability of the proposed method to support a wide range of clinical studies.
Databáze: OpenAIRE